中国农业生态(08166.HK)拟折让约6.78%配售最多1.55亿股 净筹840万港元
格隆汇9月20日丨中国农业生态(08166.HK)公告,于2019年9月20日,公司及配售代理订立配售协议,据此,公司建议提呈发售配售股份以供认购,而配售代理已同意尽最大努力促使不少于六名承配人认购配售股份。
配售事项下最多1.55亿股新股份,占经配售事项扩大的已发行股份约16.67%(假设公司股权架构于完成前并无进一步变动)。配售价0.055港元较9月20日收市价每股0.059港元折让约6.78%。
配售事项的最高所得款项净额(经扣除应付予配售代理佣金、专业费用以及于配售事项中产生的其他相关成及开支后)将约为840万港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.